English
Spanishwelcome to oneGRAVESvoice
- a positively charged Graves' disease and thyroid eye disease community.- join today!
- log in
Radioactive Iodine Can Be First-Line for Hyperthyroidism, Says UK
New UK guidelines for the treatment of hyperthyroidism, including Graves’ disease, place heavier emphasis on the use of radioactive iodine as the frontline treatment for patients unlikely to remain remission-free on the medications, as opposed to the alternative of antithyroid medications as a first choice.
“Our evidence reviews indicated that radioactive iodine is the most clinically and cost-effective treatment for hyperthyroidism,” senior author Kristien Boelaert, MD, PhD, who led the guideline committee, told Medscape Medical News.
“Recommending the use of radioactive iodine as first-line treatment for adults with Graves’ disease is a change to current practice and should reduce the variation between centers as to when radioactive iodine is considered appropriate,” the guidelines further state.
rareRelated
-
Clinical Characteristics of Patients Requiring a Second Dose of Radioactive Iodine for the Treatment of Graves’ Di...Graves’ disease is an autoimmune condi...
-
Hyperthyroidism: Should I Use Antithyroid Medicine or Radioactive Iodine?You may want to have a say in this decis...
-
Glucocorticoid Regimens for Prevention of Graves’ Ophthalmopathy Progression Following Radioiodine Treatment: ...Background: Glucocorticoid (GC) therapy...
-
Relation between Therapy Options for Graves’ Disease and the Course of Graves’ Ophthalmopathy: A Systema...Background: The relation between therap...
-
Comparative Analysis of Radioactive Iodine Versus Thyroidectomy for Definitive Treatment of Graves’ DiseaseBackground: Management of Graves diseas...
-
Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to GravesR...Background: Previous research has sugge...
-
Risk Factors For Developing Thyroid-Associated Ophthalmopathy Among Individuals with Graves’ DiseaseImportance: Thyroid-associated ophthalm...
